statistiche ricercatore

Nazione	#
IT - Italia	25.118
US - Stati Uniti d'America	821
CN - Cina	133
SG - Singapore	99
SE - Svezia	49
BR - Brasile	44
GB - Regno Unito	38
VN - Vietnam	37
UA - Ucraina	32
FR - Francia	30
DE - Germania	24
BE - Belgio	16
CA - Canada	15
IN - India	14
KR - Corea	14
FI - Finlandia	10
ES - Italia	8
IR - Iran	8
AR - Argentina	7
AU - Australia	7
JP - Giappone	7
NL - Olanda	7
TR - Turchia	7
MA - Marocco	6
HK - Hong Kong	4
MX - Messico	4
PT - Portogallo	4
RU - Federazione Russa	4
SY - Repubblica araba siriana	4
CO - Colombia	3
EC - Ecuador	3
NZ - Nuova Zelanda	3
PL - Polonia	3
RO - Romania	3
TW - Taiwan	3
AL - Albania	2
AZ - Azerbaigian	2
BD - Bangladesh	2
CL - Cile	2
EG - Egitto	2
MO - Macao, regione amministrativa speciale della Cina	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BA - Bosnia-Erzegovina	1
CG - Congo	1
CH - Svizzera	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ET - Etiopia	1
IL - Israele	1
IQ - Iraq	1
IS - Islanda	1
KN - Saint Kitts e Nevis	1
MY - Malesia	1
NG - Nigeria	1
PK - Pakistan	1
SA - Arabia Saudita	1
TJ - Tagikistan	1
UG - Uganda	1
ZA - Sudafrica	1
Totale	26.620

Nome	#
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features	3.881
What do multiple sclerosis patients and their caregivers perceive as unmet needs?	3.833
Odor identification performance in idiopathic Parkinson’s disease is associated with gender and the genetic variability of the olfactory binding protein	3.630
Parkinsonism and dementia are negative prognostic factors for the outcome of subdural hematoma	3.227
Influence of treatments in multiple sclerosis disability: a cohort study	3.148
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients	2.484
null	2.277
“Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease	2.171
6-n-propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease	1.045
GUT MICROBIOTE DISTINCTIVE FEATURES IN PARKINSON DISEASE: FOCUS ON DUODOPA AND OTHER ANTIPARKINSONIAN DRUGS	953
Totale	26.649

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3.670	0	0	0	0	0	1.022	498	502	303	525	521	299
2021/2022	1.543	233	93	66	137	121	87	61	45	209	199	188	104
2022/2023	1.970	156	324	293	188	155	182	91	111	112	130	150	78
2023/2024	1.600	45	65	50	97	139	263	203	180	76	121	193	168
2024/2025	3.218	667	880	510	394	199	231	215	19	35	21	21	26
2025/2026	347	67	35	75	55	73	42	0	0	0	0	0	0
Totale													26.649

UNICA IRIS Institutional Research Information System